NCT05155878 Prognostic Factors in Periampullary Tumors and Cysts
| NCT ID | NCT05155878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Umeå University |
| Condition | Pancreas Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2021-09-01 |
| Primary Completion | 2035-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2021-09-01 with a primary completion date of 2035-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The project aims at analysing prognostic and predictive factors involved in diagnostics and surgical treatment of cysts and tumors in the pancreas and periampullary region using both clinical data and blood and tissue samples for biomarker development and validation.
Eligibility Criteria
Inclusion Criteria: * Recommended surgery for tumor or cyst in the pancreas or periampullary region * Information avalible in electronic journal files * Informed consent (or deceased for retrospective part of the study) Exclusion Criteria: * No informed consent (and still alive at study initiation)
Contact & Investigator
Oskar Franklin, MD/PhD
PRINCIPAL INVESTIGATOR
University Hospital, Umeå
Frequently Asked Questions
Who can join the NCT05155878 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreas Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05155878 currently recruiting?
Yes, NCT05155878 is actively recruiting participants. Contact the research team at oskar.franklin@umu.se for enrollment information.
Where is the NCT05155878 trial being conducted?
This trial is being conducted at Umeå, Sweden.
Who is sponsoring the NCT05155878 clinical trial?
NCT05155878 is sponsored by Umeå University. The principal investigator is Oskar Franklin, MD/PhD at University Hospital, Umeå. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.